← Leaderboards
Vicente E Torres
Mayo Clinic Coll Of Medicine, Rochester
$21,998,835
Attributed
$21,998,835
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.9M · FY2005–19$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$33,779,755 · 10
By mechanism
U01$15,356,964 · 2
P30$12,651,838 · 2
R01$4,514,348 · 1
T32$1,056,336 · 1
R56$119,250 · 1
M01$71,019 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsPolycystic Kidney DiseasesAutosomal Dominant Polycystic KidneyKidneyResearch PersonnelPhenotypeDisease ProgressionAffectEnd Stage Renal FailureProgramsGeneticGrantTechnologyTransgenic OrganismsKidney FailureImageClinical ResearchBaseSignal TransductionKidney DiseasesInnovationCystBiological ModelsProteins
Grant awards (85)
Mayo Translational PKD Center (MTPC)$1,157,354
P30 · FY2019 · DK · contact PI
Novel treatment for polycystic kidney disease$357,750
R01 · FY2019 · DK · contact PI
Administrative Core$166,244
P30 · FY2019 · DK · contact PI
Mayo Translational PKD Center (MTPC)$40,799
P30 · FY2019 · DK · contact PI
Mayo Translational PKD Center (MTPC)$1,157,354
P30 · FY2018 · DK · contact PI
Novel treatment for polycystic kidney disease$357,750
R01 · FY2018 · DK · contact PI
Administrative Core$166,244
P30 · FY2018 · DK · contact PI
Administrative Core$39,701
P30 · FY2018 · DK · contact PI
Mayo Translational PKD Center (MTPC)$39,701
P30 · FY2018 · DK · contact PI
Mayo Translational PKD Center (MTPC)$1,157,354
P30 · FY2017 · DK · contact PI
Novel treatment for polycystic kidney disease$357,750
R01 · FY2017 · DK · contact PI
Administrative Core$166,243
P30 · FY2017 · DK · contact PI
FASEB SRC on Polycystic Kidney Disease: Challenges, differing viewpoints and ways forward$10,000
R13 · FY2017 · DK · contact PI
Mayo Translational PKD Center (MTPC)$1,157,354
P30 · FY2016 · DK · contact PI
Novel treatment for polycystic kidney disease$357,750
R01 · FY2016 · DK · contact PI
Administrative Core$166,243
P30 · FY2016 · DK · contact PI
Mayo Translational PKD Center (MTPC)$47,700
P30 · FY2016 · DK · contact PI
Mayo Translational PKD Center (MTPC)$1,157,354
P30 · FY2015 · DK · contact PI
Administrative Core$166,243
P30 · FY2015 · DK · contact PI
Novel treatment for polycystic kidney disease$119,250
R56 · FY2015 · DK · contact PI
Mayo Translational PKD Center (MTPC)$1,116,065
P30 · FY2014 · DK · contact PI
Novel treatment for polycystic kidney disease$351,009
R01 · FY2014 · DK · contact PI
PKD, Innovative Imaging to Assess Progression (PCC)$336,349
U01 · FY2014 · DK · contact PI
Mayo Translational PKD Center (MTPC)$36,000
P30 · FY2014 · DK · contact PI
Mayo Translational PKD Center (MTPC)$1,073,863
P30 · FY2013 · DK · contact PI
Controlled Trial of Renin Angiotensin Blockade in ADPKD$895,775
U01 · FY2013 · DK · contact PI
PKD, Innovative Imaging to Assess Progression (PCC)$340,928
U01 · FY2013 · DK · contact PI
Novel treatment for polycystic kidney disease$312,617
R01 · FY2013 · DK · contact PI
Novel treatment for polycystic kidney disease$45,089
R01 · FY2013 · DK · contact PI
Mayo Translational PKD Center (MTPC)$36,000
P30 · FY2013 · DK · contact PI
Mayo Translational PKD Center (MTPC)$1,160,773
P30 · FY2012 · DK · contact PI
Controlled Trial of Renin Angiotensin Blockade in ADPKD$945,775
U01 · FY2012 · DK · contact PI
PKD, Innovative Imaging to Assess Progression (PCC)$345,765
U01 · FY2012 · DK · contact PI
Novel treatment for polycystic kidney disease$323,955
R01 · FY2012 · DK · contact PI
Mayo Translational PKD Center (MTPC)$38,880
P30 · FY2012 · DK · contact PI
Mayo Translational PKD Center (MTPC)$1,182,744
P30 · FY2011 · DK · contact PI
Controlled Trial of Renin Angiotensin Blockade in ADPKD$945,775
U01 · FY2011 · DK · contact PI
Novel treatment for polycystic kidney disease$323,955
R01 · FY2011 · DK · contact PI
PKD, Innovative Imaging to Assess Progression (PCC)$316,330
U01 · FY2011 · DK · contact PI
Mayo Translational PKD Center (MTPC)$38,880
P30 · FY2011 · DK · contact PI
Mayo Translational PKD Center (MTPC)$1,182,745
P30 · FY2010 · DK · contact PI
Controlled Trial of Renin Angiotensin Blockade in ADPKD$945,775
U01 · FY2010 · DK · contact PI
Novel treatment for polycystic kidney disease$394,250
R01 · FY2010 · DK · contact PI
Polycystic Kidney Disease: Innovative Imaging to Assess Progression (PCC)$334,788
U01 · FY2010 · DK · contact PI
Controlled Trial of Renin Angiotensin Blockade in ADPKD$974,850
U01 · FY2009 · DK · contact PI
Controlled Trial of Renin Angiotensin Blockade in ADPKD$423,547
U01 · FY2009 · DK · contact PI
Polycystic Kidney Disease: Innovative Imaging to Assess Progression (PCC)$334,817
U01 · FY2009 · DK · contact PI
Kidney Disease Research Training Program$101,875
T32 · FY2009 · DK · contact PI
Novel treatments for polycystic kidney disease$75,000
R01 · FY2009 · DK · contact PI
Controlled Trial of Renin Angiotensin Blockade in ADPKD$880,697
U01 · FY2008 · DK · contact PI
Polycystic Kidney Disease: Innovative Imaging to Assess Progression (PCC)$369,513
U01 · FY2008 · DK · contact PI
Novel treatments for polycystic kidney disease$211,251
R01 · FY2008 · DK · contact PI
Kidney Disease Research Training Program$143,971
T32 · FY2008 · DK · contact PI
Controlled Trial of Renin Angiotensin Blockade in ADPKD$1,200,788
U01 · FY2007 · DK · contact PI
Polycystic Kidney Disease: Innovative Imaging to Assess Progression (PCC)$339,469
U01 · FY2007 · DK · contact PI
Novel treatments for polycystic kidney disease$215,562
R01 · FY2007 · DK · contact PI
Kidney Disease Research Training Program$155,061
T32 · FY2007 · DK · contact PI
Controlled Trial of Renin Angiotensin Blockade in ADPKD$400,000
U01 · FY2006 · DK · contact PI
PKD Innovative Imaging to Assess Progression (PCC)$321,845
U01 · FY2006 · DK · contact PI
Novel treatments for polycystic kidney disease$222,000
R01 · FY2006 · DK · contact PI
Kidney Disease Research Training Program$117,057
T32 · FY2006 · DK · contact PI
Controlled Trial of Renin Angiotensin Blockade in ADPKD$259,285
U01 · FY2005 · DK
Kidney Disease Research Training Program$183,905
T32 · FY2005 · DK
PROGRESSION OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE$36,489
M01 · FY2005 · RR
Controlled Trial of Renin Angiotensin Blockade in ADPKD$761,932
U01 · FY2004 · DK
PKD, INNOVATIVE IMAGING TO ASSESS PROGRESSION (PCC)$500,000
U01 · FY2004 · DK
Kidney Disease Research Training Program$189,776
T32 · FY2004 · DK
PKD, INNOVATIVE IMAGING TO ASSESS PROGRESSION (PCC)$67,394
U01 · FY2004 · DK
Renal Imaging to Assess Progression of ADPKD$34,530
M01 · FY2004 · RR
Controlled Trial of Renin Angiotensin Blockade in ADPKD$570,225
U01 · FY2003 · DK
PKD, INNOVATIVE IMAGING TO ASSESS PROGRESSION (PCC)$500,000
U01 · FY2003 · DK
Kidney Disease Research Training Program$164,691
T32 · FY2003 · DK
Controlled Trial of Renin Angiotensin Blockade in ADPKD$73,000
U01 · FY2003 · DK
PKD, INNOVATIVE IMAGING TO ASSESS PROGRESSION (PCC)$50,000
U01 · FY2003 · DK
PKD, INNOVATIVE IMAGING TO ASSESS PROGRESSION (PCC)$500,000
U01 · FY2002 · DK
Controlled Trial of Renin Angiotensin Blockade in ADPKD$250,000
U01 · FY2002 · DK
Controlled Trial of Renin Angiotensin Blockade in ADPKD$208,780
U01 · FY2002 · DK
REDOX, ACID/BASE, AND PATHOGENESIS OF ADPKD$205,531
R01 · FY2002 · DK
GENETICS OF AUTOSOMAL DOMINANT POLYCYSTIC LIVER DISEASE$0
M01 · FY2002 · RR
PKD, INNOVATIVE IMAGING TO ASSESS PROGRESSION (PCC)$500,000
U01 · FY2001 · DK
REDOX, ACID/BASE, AND PATHOGENESIS OF ADPKD$199,543
R01 · FY2001 · DK
GENETICS OF AUTOSOMAL DOMINANT POLYCYSTIC LIVER DISEASE$0
M01 · FY2001 · RR
PKD, INNOVATIVE IMAGING TO ASSESS PROGRESSION (PCC)$463,562
U01 · FY2000 · DK
REDOX, ACID/BASE, AND PATHOGENESIS OF ADPKD$203,586
R01 · FY2000 · DK
GENETICS OF AUTOSOMAL DOMINANT POLYCYSTIC LIVER DISEASE$0
M01 · FY2000 · RR